Efficacy of regorafenib combined with PD-1 inhibitors in elderly patients with advanced metastatic colorectal cancer

Efficacy of regorafenib combined with PD-1 inhibitors in elderly patients with advanced metastatic colorectal cancer

Abstract Objective This is the first clinical study that wants to investigate the treatment patterns, clinical outcomes, and prognostic factors of regorafenib plus PD-1 inhibitors therapy in Chinese elderly patients with advanced colorectal cancer. Methods A cohort of metastatic colorectal cancer pa...

Full description

Bibliographic Details
Main Authors: Beibei Chen, Huichen Zhao, Jinxi Huang, Huifang Lv, Weifeng Xu, Caiyun Nie, Jianzheng Wang, Jing Zhao, Yunduan He, Saiqi Wang, Xiaobing Chen
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Geriatrics
Subjects:
Colorectal cancer
Elderly patients
Immunotherapy
Programmed cell death protein 1
Regorafenib
Online Access:https://doi.org/10.1186/s12877-022-03637-9

Internet

https://doi.org/10.1186/s12877-022-03637-9

Similar Items